Successful treatment of vitiligo with a sex steroid-thyroid hormone mixture.

Abstract

Four patients with generalized vitiligo were successfully treated by oral administration of a sex steroid-thyroid hormone (Metharmon-F, 2 tablets daily). Histopathologically, the repigmented skin showed increased numbers of melanocytes and melanin granules in the keratinocytes.

• Authors: M Muto, H Furumoto, A Ohmura, C Asagami
• Journal: The Journal of dermatology (J Dermatol) Vol. 22 Issue 10 Pg. 770-2 (Oct 1995) ISSN: 0385-2407 [Print] England
• PMID: 8586759 (Publication Type: Case Reports, Journal Article)

Chemical References

• Dermatologic Agents
• Drug Combinations
• Melanins
• Tablets
• Thyroid (USP)
• Estrone
• Testosterone
• Androstenedione
• Pregnenolone
• Metharmon F
• Androstenediol

Topics

• Administration, Oral
• Aged
• Androstenediol (administration & dosage, therapeutic use)
• Androstenedione (administration & dosage, therapeutic use)
• Cytoplasmic Granules (drug effects, ultrastructure)
• Dermatologic Agents (administration & dosage, therapeutic use)
• Drug Combinations
• Estrone (administration & dosage, therapeutic use)
• Female
• Humans
• Keratinocytes (drug effects, pathology)
• Male
• Melanins
• Melanocytes (drug effects, pathology)
• Middle Aged
• Pregnenolone (administration & dosage, therapeutic use)
• Skin Pigmentation (drug effects)
• Tablets
• Testosterone (administration & dosage, therapeutic use)
• Thyroid (USP) (administration & dosage, therapeutic use)
• Vitiligo (drug therapy, pathology)